Literature DB >> 18929523

VWF attributes--impact on thrombus formation.

Armin J Reininger1.   

Abstract

At sites of vascular injury, free-flowing platelets attach to the vessel wall to initiate thrombus formation in areas of high haemodynamic shear stress, a process that is critical for both haemostasis and thrombosis. This reaction is mediated by the binding of the platelet glycoprotein (GP) Iba to the A1 domain of immobilized von Willebrand factor (VWF), resulting in a complex series of events that includes platelet adhesion, activation and aggregation. Under elevated rates of shear stress these events support the formation of platelet-derived tethers and microparticles (MPs), which contain adhesive receptors and glycoproteins, and can bind to immobilized and soluble VWF, thereby facilitating thrombus formation. Understanding of the unique functional attributes of VWF has helped elucidate the interaction between VWF and platelets and its subsequent impact on thrombus formation. This interaction is multifaceted and modulated by different environmental conditions. A novel mechanism for initiating thrombus formation under high haemodynamic forces has recently been demonstrated. Results from direct real-time visualization of blood flow studies demonstrate activation-independent platelet aggregation, which occurs exclusively through binding of soluble VWF to platelet GPIb at very high shear stress, and may thus contribute to acute thrombotic occlusion. This article reviews the attributes of VWF and their impact on thrombus formation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18929523     DOI: 10.1016/S0049-3848(08)70028-8

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  14 in total

1.  Enzymes that hydrolyze adenine nucleotides in platelets and polymorphisms in the alpha2 gene of integrin alpha2beta1 in patients with von Willebrand disease.

Authors:  Karen Freitas Santos; Vanessa Battisti; Maísa de Carvalho Corrêa; Thaís Rapachi Mann; Renata da Silva Pereira; Maria do Carmo Araújo; Alice Odete Brülê; Maria Rosa Chitolina Schetinger; Vera Maria Morsch
Journal:  Mol Cell Biochem       Date:  2010-03-25       Impact factor: 3.396

Review 2.  Laboratory testing for von Willebrand disease: toward a mechanism-based classification.

Authors:  Richard Torres; Yuri Fedoriw
Journal:  Clin Lab Med       Date:  2009-06       Impact factor: 1.935

3.  Computational fluid dynamics analysis to determine shear stresses and rates in a centrifugal left ventricular assist device.

Authors:  Brian Paul Selgrade; George A Truskey
Journal:  Artif Organs       Date:  2012-02-23       Impact factor: 3.094

4.  The crystal structure of the active domain of Anopheles anti-platelet protein, a powerful anti-coagulant, in complex with an antibody.

Authors:  Kanako Sugiyama; Mitsuhiro Iyori; Asuka Sawaguchi; Satoko Akashi; Jeremy R H Tame; Sam-Yong Park; Shigeto Yoshida
Journal:  J Biol Chem       Date:  2014-04-24       Impact factor: 5.157

5.  Antiplatelet pretreatment does not increase hematoma volume in experimental intracerebral hemorrhage.

Authors:  Arne Lauer; Frieder Schlunk; Elizabeth M Van Cott; Helmuth Steinmetz; Eng H Lo; Christian Foerch
Journal:  J Cereb Blood Flow Metab       Date:  2011-03-09       Impact factor: 6.200

6.  Von Willebrand factor-A1 domain binds platelet glycoprotein Ibα in multiple states with distinctive force-dependent dissociation kinetics.

Authors:  Lining Ju; Yunfeng Chen; Fangyuan Zhou; Hang Lu; Miguel A Cruz; Cheng Zhu
Journal:  Thromb Res       Date:  2015-06-20       Impact factor: 3.944

Review 7.  Fibrinogen adsorption to biomaterials.

Authors:  Thomas A Horbett
Journal:  J Biomed Mater Res A       Date:  2018-09-08       Impact factor: 4.396

Review 8.  Natural Products for Antithrombosis.

Authors:  Cen Chen; Feng-Qing Yang; Qian Zhang; Feng-Qin Wang; Yuan-Jia Hu; Zhi-Ning Xia
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-17       Impact factor: 2.629

9.  Proteomic characterization of HIV-modulated membrane receptors, kinases and signaling proteins involved in novel angiogenic pathways.

Authors:  Suraiya Rasheed; Jasper S Yan; Adil Hussain; Bruce Lai
Journal:  J Transl Med       Date:  2009-08-27       Impact factor: 5.531

10.  von Willebrand Factor Propeptide: A Potential Disease Biomarker Not Affected by ABO Blood Groups.

Authors:  Mahat Marianor; Abdullah Wan Zaidah; Ch Che Maraina
Journal:  Biomark Insights       Date:  2015-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.